Saint Francis Hospital in Memphis, Tennessee, is the latest healthcare provider to adopt the da Vinci Surgical System SI – a robotic revolution transforming medicine.
The $1.6 million investment will make Saint Francis the sixth hospital in the region with a da Vinci system in place. According to the Memphis Commercial Appeal, doctors have already performed 10 procedures with the equipment since its installation last month.
"It's just better for the patients," hospital vice president, Marilynn Robinson, told the news source. "We're finding without any question that the length of patients' stays are reduced, and complications have been reduced."
Since its debut in 1996, adoption rates for the da Vinci system have grown steadily, aided by its approval by the U.S. Food and Drug Administration. Much of its success can also be attributed to its utility in prostate surgery and hysterectomies. The minimally-invasive techniques provide a host of benefits to patients, including less blood loss, scarring and pain along with shorter recovery times. And according to the Business Review, the intuitive controls and high-definition magnification of the surgical area make it easier for surgeons to complete delicate procedures.
"The best feature of the robot is that it allows the surgeon to have the instruments, which are our hands, and the camera, which is our eyes, in the body at the same time without compromising the ability to perform the procedure," Dr. John Wilbanks of Alabama's Shelby Baptist Medical Center told MD News.
To coincide with the debut of the da Vinci system, Saint Francis will be hosting a prostate health forum alongside members of the American Urological Association Foundation and the National Football League. According to the Memphis Daily News, industry leading urologists will be in attendance to discuss the early warning signs of prostate cancer as well as potential treatment options. The event will conclude with a question and answer session as well as the opportunity to undergo a free prostate health screening.
The hospital's da Vinci system will also be on display as doctors explain the technology and its associated benefits.
"Men with prostate cancer are having phenomenal results with it, so we definitely wanted them to have the opportunity to see it and get the experience of what it looks like and how it operates," Robinson told the news source.
Although only 150 guests are expected at the event, its impact will extend far beyond the conference hall. As more hospitals and more patients recognize the clear benefits that robotics can bring to medicine, the technology should be poised for widespread adoption and future innovations.